No Detail Found!

Factors A ecting Pathological Complete Response After Neoadjuvant Chemotherapy in Operable Primary Breast Cancer

Author(s)
Yanli Lv Breast Center, Shunyi District Health Care Hospital for Women and Children of Beijing,Beijing,P.R. China
Yi Li Breast Center, Shunyi District Health Care Hospital for Women and Children of Beijing,Beijing,P.R. China
Weimin Mu Breast Center, Shunyi District Health Care Hospital for Women and Children of Beijing,Beijing,P.R. China
Hui Fu Breast Center, Shunyi District Health Care Hospital for Women and Children of Beijing,Beijing,P.R. China
Abstract
Objective: To investigate factors in uencing pathological response to neoadjuvant chemotherapy (NAC) in operable primary breast cancer. Study Design: Descriptive study. Place and Duration of Study: Breast Center, Shunyi District Health Care Hospital for Women and Children of Beijing, Beijing 101300, P.R. China, from January 2009 to December 2017. Methodology: Two hundred and sixty-one operable primary invasive breast cancer patients treated with NAC were included in this observational study. Pathological complete response (pCR) was de ned as no residual invasive disease in either the breast or the axillary lymph nodes, with non-invasive breast residuals permitted (ypT0/is ypN0). Factors a ecting pCR were subjected to univariate and multivariate analysis. Results: Seventy-six patients (29.1%) achieved pCR after NAC. Tumor size, histological grade, status of estrogen receptor (ER) and progesterone receptor (PgR), expression of human epidermal growth factor receptor 2 (HER2) and Ki67, axillary lymph node status, and chemotherapy regimen were all signi cantly associated with pCR inunivariate analysis (all p<0.05). In multivariate analysis, high histological grade, negative HR status and lymph nodes, positive HER2 status, and taxane-based regimens were independent predictive factors of pCR. Patients with HER2-positive tumors were more sensitive to NAC regimen including trastuzumab. Conclusion: In this study, breast cancer patients with high histological grade, negative HR status and lymph nodes, positive HER2 status, as well as taxane-based regimens were signi cantly associated with achieving pCR with NAC.
Publication Details
Page(s) 389-393
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 30, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
Surgery, Neoadjuvant therapy, Pathology, Breast neoplasms
0

Citations

0

Downloads

60

Views